Molecular Diagnostic Space - Opportunities and Growth Indicators
The "Connected CEO": Creating a Powerful Growth Opportunity Pipeline
- Integrate remote patient monitoring to advance digital sleep care.
- How is AI-powered sleep analytics improving therapy effectiveness?
- Assess key innovations across neuromodulation systems.
- Leverage surgical robotics for high precision subretinal processes.
- Utilize the rising demand for non-invasive monitoring platforms.
- Converge AI and wearable sensors to enable real-time analytics.
Introducing Frost & Sullivan’s Healthcare and Life Sciences LinkedIn Page
Transformation Growth Perspectives
Explore our growth-oriented whitepapers that translate industry disruption and strategic imperatives into actionable growth opportunities, competitive benchmarking, companies-to-action, and best practices to accelerate performance and drive sustainable competitive advantage.
Explore Executive Perspectives on Business Transformation
Interview with Harshit Jain
Transforming Healthcare Marketing Through AI, EHR Intelligence, and Platform Innovation
Harshit Jain
Founder & Global CEO | Doceree
Interview with Eron Kelly
From AI Assistance to Agentic Execution: A Conversation on the Future of Data-driven Healthcare
Eron Kelly
CEO | ConcertAI
Interview with Fumihide Esaka
From Edge AI to Intelligent Healthcare: How Ambiq Is Enabling the Next Generation of Connected Medical Devices
Fumihide Esaka
CEO | Ambiq
Interview with Dr. Nurul Mu’az Bin Omar
Transforming Care, Driving Value: Selgate Healthcare’s Strategy for Patient-centric Care in Malaysia
Dr. Nurul Mu’az Bin Omar
Managing Director & CEO | Selgate Healthcare
Interview with Dr. Sud Agarwal
Reimagining the CRO Model: How iNGENu CRO Is Using AI and Automation to Transform Clinical Trial Execution
Dr. Sud Agarwal
CEO | iNGENu CRO
Navigating Transformation – Middle East (June 2026 Edition)
How can your organization thrive amidst the transformation of the ever-evolving NG911 and 5G industries?
Next Generation 911 in the United States
- How can you address growth gaps to outperform competitors in public safety?
- Capitalize on key prospects by aligning organizational design with innovations.
- Identify opportunities reshaping the next generation 911 (NG911) landscape.
Private 5G Network Landscape
- Are you equipped with new technologies to thrive amidst transformation?
- Maximize growth by harnessing networks to enhance performance.
- Align your strategy with megatrends reshaping private 5G networks.
Examine growth avenues in behavioral health management, conversational AI, and revenue cycle management (RCM).

Learn more

Learn more

Learn more
Frost & Sullivan Brand and Demand Solutions

Capture growth across landscapes like self-powered sensors in biomedical applications and AI-enabled clinical trials.
The Growth Innovation Leadership Council
How can your team grow rapidly in the ABM platform, content delivery network, and cloud service industries?
Enabling Secure, AI-ready Cloud Transformation Across the Americas: CloudHesive’s Growth Journey
As organizations across industries accelerate cloud modernization, AI adoption, and digital transformation, CloudHesive is helping customers build secure, scalable, and future-ready technology foundations. In this exclusive Movers and Shakers conversation, Fernando Castillo, LATAM Executive Director at CloudHesive, shares the company’s growth journey, its role in supporting transformation across the United States and Latin America, and its vision for helping customers move from cloud adoption to long-term business value. Frost & Sullivan’s Alejandra Parra spoke with Castillo at HIMSS Argentina 2026 to explore how CloudHesive is helping enterprises modernize critical operations, strengthen resilience, and prepare for the next wave of AI-enabled transformation.
Top 50 Technologies 2026: Prioritizing Innovation to Drive Near-term Growth and Strategic Decisions
Frost & Sullivan’s TechVision Growth Webinar, “Top 50 Technologies for 2026; Technologies Driving Multibillion Dollar Growth Opportunities”, featured experts who discussed how emerging technologies are being prioritized across nine technology clusters, how organizations are assessing innovation readiness, and how decision makers are navigating competing investment priorities. The session also highlighted key technologies gaining momentum, audience perspectives on growth impact, and the structured methodology used to identify the technologies expected to shape commercialization opportunities over the next two to three years.
Global Pharmaceutical Industry Faces a High-stakes Reset as AI, Biologics, and Supply Resilience Redefine Growth Through 2031
Frost & Sullivan’s latest analysis, Growth Opportunities in Global Pharmaceutical Industry, 2026, finds that the pharmaceutical industry is entering a period of profound transformation as affordability mandates, patent expiries, geopolitical fragmentation, and rapid technological advances reshape the foundations of value creation.
Healthcare Cloud Transformation: From Migration to AI Readiness
For years, healthcare organizations treated the cloud as an infrastructure problem. Today, that perspective has changed with cloud becoming the foundation for AI initiatives, distributed care delivery, operational efficiency, and cyber resilience. These themes were at the center of Frost & Sullivan’s recent webinar, “Driving Healthcare IT Transformation: Growth Opportunities Enabled by Cloud,” in which industry experts discussed where the industry is heading and what healthcare organizations need to prioritize to stay competitive.
From Breakthroughs to Industrial-scale Impact: Scaling Cell and Gene Therapy for Commercial Success
Cell and gene therapy (CGT) encompasses advanced therapeutic approaches that modify or replace genetic material and cells to treat, prevent, or potentially cure diseases. These therapies span in vivo and ex vivo gene therapies, gene-modified cell therapies, and next-generation platforms like CRISPR-based editing and allogeneic “off-the-shelf” solutions.
Aileen.ai Receives the 2026 North American Transformational Innovation Leadership Recognition for Advancing Relationship-based AI-enabled Senior Care
Frost & Sullivan is pleased to announce that Aileen.ai has been honored with the 2026 North American Transformational Innovation Leadership Recognition in the AI health companion for seniors industry for its outstanding achievements in product innovation, customer experience, and care delivery transformation.
Check out the latest news covering key industry developments and major company highlights to stay up-to-date in the healthcare and life sciences landscape.
- China closing in but US leads in biotech quality, commercial reach
- Germany's Merck boosts life sciences business with $11 billion bet on Bio-Techne
- Big Europe and Asian private equity health funds merge to defy AI disruption
- The Healthcare M&A Wave
- Major deals involving US drugmakers and biotechs over the past decade
Frost & Sullivan Institute
Click Here to explore our latest blog on "Telemedicine, Wearables & mHealth: Transforming Healthcare Access for the Vulnerable Populations".
Click Here to explore our latest blog on "Health and Socioeconomic Determinants of Life Expectancy in Africa: A Panel ARDL Analysis".
Click Here to explore our latest blog on "Femtech: Revolutionizing Women’s Health Through Innovation".
Capture growth across smart delivery formulations, AI-enabled clinical trials, and microbiome technologies.
Frost Growth Expert Network
Explore a wide range of Growth Webinars and Growth Podcasts highlighting emerging opportunities in the healthcare and life sciences landscape.
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
CDMO Live Americas
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Global Health Exhibition
Dates: 26th - 29th October 2026
Venue: Malham, Riyadh, Saudi Arabia.
Established in 2018, Global Health Exhibition (GHE) is Saudi Arabia’s premier platform for driving healthcare transformation and innovation. Positioned as the global stage for healthcare evolution, GHE serves as a strategic meeting point for the world’s healthcare innovators, investors, and leaders. Organised by Tahaluf, a strategic alliance between Informa PLC, the Saudi Arabian Federation for Cyber Security and Programming (SAFCSP), and the Events Investment Fund (EIF), the event plays a pivotal role in advancing the Kingdom’s Vision 2030 Health Sector Transformation Program.
Hosted at the Riyadh Exhibition & Conference Center (Malham), GHE showcases groundbreaking technologies, including AI in diagnostics, genomic medicine, and telemedicine, while fostering public-private partnerships to reshape the future of healthcare in Saudi Arabia and beyond. Recognised for its excellence, GHE is an award-winning show, having been honored with the EN Awards for Best Trade Show over 10,000 SQM for its 2025 edition and previously awarded the AEO Best International Show – Middle East & Africa.
.
Bio Middle East
Dates: 14th to 16th December 2026
Venue: Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
BIO Middle East is the region’s dedicated biotechnology event, bringing together biotech innovators, pharmaceutical leaders, investors, researchers and policymakers. Taking place in Riyadh, Saudi Arabia, the event focuses on advancing biotechnology, biomanufacturing, precision medicine, investment and R&D partnerships, creating opportunities for collaboration and business growth across the Middle East and beyond.
CDMO Live Europe
Dates: May 19-21, 2026
Venue: Rotterdam
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Medical Fair India 2026
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
CDMO Live Americas
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Dates: May 19-21, 2026
Venue: Rotterdam
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series that connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Register Now
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series that connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Register Now
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
Register Now
Growth
Let's Talk About Your Project
Examine she brother prudent add day ham. Far stairs now coming bed oppose hunted become his. You zealously departure had procuring suspicion. Books whose front would purse if be do decay. Quitting you way formerly disposed perceive ladyship are.
